Well Told Grants

Grants / Department of Health and Human Services / Food and Drug Administration

RFA-FD-22-026: Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional

Closed Closed May 9, 2022 Opportunity RFA-FD-22-026

This grant is closed. A newer notice from the same program is open now: Flexible Funding Model - Advancing Domestic Mutual Reliance Through Strengthened Infrastructure Development and Maintenance for Manufactured Food Regulatory Programs (PAR-27-017). Status: Rolling or no fixed deadline. It is in our archive of Food and Drug Administration notices from 2022.

Food and Drug Administration offered grants of up to $1.0 million (at least $50,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 5 awards. Applications closed on May 9, 2022.

From the official notice on Grants.gov, last changed March 4, 2022. Checked November 7, 2026.

Other notices with this title

Food and Drug Administration has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
RFA-FD-23-026February 16, 2023Closed April 26, 2023Closed

Key dates

PostedMarch 4, 2022
DeadlineMay 9, 2022
Archived by Grants.govJune 8, 2022

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

1. Eligible Applicants Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Non-domestic (non-U.S) Entities (Foreign Institutions)

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The purpose of this Funding Opportunity Announcement (FOA) is to support research projects that enhance biosimilar and interchangeable biological product development and regulatory science.

Category: Consumer Protection, Science and Technology and other Research and Development.

Who has won Food and Drug Administration Research grants before

From fiscal 2021 to 2025, Food and Drug Administration Research (93.103) awarded $1.2 billion across 940 grant awards, an average of $1.3 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The Critical Path InstituteArizona13$94.0 million
National Environmental Health AssociationColorado9$55.4 million
Association of Food & Drug OfficialsPennsylvania14$50.3 million
The Medical Device Innovation ConsortiumVirginia1$48.6 million
Duke UniversityNorth Carolina11$35.6 million

Top states: Arizona ($102 million), California ($95.7 million), Pennsylvania ($83.3 million), Maryland ($80.1 million), Virginia ($79.7 million).

Applying now

This notice no longer takes applications. Apply under the newer notice, PAR-27-017, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-FD-22-026 still open?

No. It closed on May 9, 2022. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

Who can apply for Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional?

Food and Drug Administration accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional?

Closed May 9, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $1.0 million each.

Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.

Similar open grants